Genetic Characterization of Cardiomyopathies (POLICARDIOMIO2021)

Status Recruiting

Clinical Trial Summary

Cardiomyopathy refers to a diverse group of myocardial diseases with multiple causes. In 1995, the World Health Organization classified cardiomyopathies into hypertrophic, dilated, restrictive, and mixed type. This classification is based on the pathophysiology of the disease. However, with rapid evolution of molecular genetics in cardiology, the American Heart Association in 2006 has classified cardiomyopathies into two major groups based on predominant organ involvement and etiology; Primary cardiomyopathies are those solely or predominantly confined to heart muscle and are relatively few in number. Secondary cardiomyopathies show pathologic myocardial involvement as part of a large number and variety of generalized systemic (multiorgan) disorders.Current evidence supports the use of genetic testing in clinical practice to improve risk stratification for clinically affected patients and their at-risk relatives for cardiomyopathies.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cardiomyopathies

Clinical Trial Details

NCT number	NCT05556369
Study type	Observational
Source	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Contact	Stefano Carugo, Principal Investigator
Phone	+39 0255033579
Email	stefano.carugo@policlinico.mi.it
Status	Recruiting
Phase
Start date	September 1, 2021
Completion date	September 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05428787` - Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing	N/A
Not yet recruiting	`NCT05567445` - Outcome of Cardiomyopathic Adults Admission in ICU.
Completed	`NCT02555527` - Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment	N/A
Completed	`NCT00371891` - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)	Phase 4
Recruiting	`NCT05552521` - Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
Recruiting	`NCT04166331` - Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion	Phase 3
Terminated	`NCT06331507` - Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch	N/A
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Recruiting	`NCT04695119` - Sepsis in the ICU-II
Completed	`NCT03228966` - Ped HIV - Echo Study: Kenya
Not yet recruiting	`NCT06348732` - Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings
Recruiting	`NCT04520646` - A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy	N/A
Not yet recruiting	`NCT03899298` - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions	Phase 1
Completed	`NCT04323852` - Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?	Phase 4
Completed	`NCT03527381` - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery	Phase 1/Phase 2
Withdrawn	`NCT02462213` - Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging	N/A
Active, not recruiting	`NCT00418041` - Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)	N/A
Not yet recruiting	`NCT06091475` - Therapy to Maintain Remission in Dilated Cardiomyopathy	N/A
Recruiting	`NCT03317964` - Genetic Basis of Pacing-induced Cardiomyopathy
Terminated	`NCT03704701` - The Interrogation of the Cardiomyopathy of Chronic Kidney Disease With advancEd caRdiac Imaging